Krsnaa Diagnostics Ltd (KRSNAA) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management has strong conviction in collecting 200 crores of overdue receivables in Q3 FY27, addressing a key investor concern on working capital.
- The company is strategically shifting its business mix, aiming for cash-based revenues from retail and PPP projects to contribute 40-45% of total revenue by FY27-end.
- Q2 EBITDA margin of 27% is considered the bottom, with an expected uptick as the Rajasthan project scales against largely absorbed upfront costs.
Performance Overview
- Krsnaa Diagnostics delivered its highest-ever quarterly revenue, driven by newly operationalized projects and continued growth in existing business.
- The company crossed a significant milestone, achieving over 507 crores in revenue for the first half of the fiscal year, a 27% year-on-year increase.
- EBITDA margins saw a temporary moderation due to upfront operating costs associated with large-scale project implementations, notably in Rajasthan.
- A key management priority is improving the collection cycle, with a stated visibility on potential collections of around 200 crores in Q3 FY27.
- The strategic shift towards increasing cash-based revenues is showing results, with a target for cash-based revenues to reach 40-45% of the total mix by the end of FY27.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.